HPV Vaccine Study for Rural Kids 8 to 12
Part of Cancer, Infections clinical trials.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 8 and 12 years old.
- Your child must have visited the clinic in the past year or be willing to come in for the study.
- Your child cannot have already received both doses of the HPV vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is interviewing girls ages 9 to 14 and their caregivers in Ethiopia to learn how to better integrate HPV vaccination into routine health services. If you received an HPV vaccine or other VYA service on the day you were recruited, you may be able to share your experience.
This study tests whether real-time reminders and guidance help families stay on track with the HPV vaccine for children who are 11–12 years old. It’s a “feasibility” study, meaning it focuses on whether the approach is practical and acceptable.
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
This study helps make sure kids get the HPV vaccine during routine checkups. It is for children who have not yet had any dose of the HPV vaccine.
This trial tests a program at school health centers to help teens get their HPV vaccine and learn about wellness. If you're due for the HPV shot, this could be a helpful way to get it in a familiar place.
This study looks at ways to make it easier for preteens aged 10 to 12 to get the HPV vaccine, which protects against certain cancers. It aims to see if simple reminders or education can increase vaccination rates.
Hear when a new Papillomavirus Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.